Wang Q - Search Results

1

RAC1 serves as a prognostic factor and correlated with immune infiltration in liver hepatocellular carcinoma.

Li Y, Gu A, Yang L, Wang Q. Li Y, et al. Among authors: wang q. J Cancer Res Clin Oncol. 2024 Sep 12;150(9):418. doi: 10.1007/s00432-024-05933-w. J Cancer Res Clin Oncol. 2024. PMID: 39264423 Free PMC article.

2

Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma.

Wen S, Chen Y, Hu C, Du X, Xia J, Wang X, Zhu W, Wang Q, Zhu M, Chen Y, Shen B. Wen S, et al. Among authors: wang x, wang q. Front Immunol. 2022 Jan 13;12:788640. doi: 10.3389/fimmu.2021.788640. eCollection 2021. Front Immunol. 2022. PMID: 35095864 Free PMC article.

3

Prognostic value of angiogenic T cells in hepatitis B-induced liver cirrhosis.

He QL, Wang QB, Yi CH, Yang XJ, Yu JH. He QL, et al. Diagn Microbiol Infect Dis. 2024 Jun;109(2):116264. doi: 10.1016/j.diagmicrobio.2024.116264. Epub 2024 Mar 13. Diagn Microbiol Infect Dis. 2024. PMID: 38493510

4

Tumor-associated lymphatic vessel density is a reliable biomarker for prognosis of esophageal cancer after radical resection: a systemic review and meta-analysis.

Li J, Wang QB, Liang YB, Chen XM, Luo WL, Li YK, Chen X, Lu QY, Ke Y. Li J, et al. Front Immunol. 2024 Sep 20;15:1453482. doi: 10.3389/fimmu.2024.1453482. eCollection 2024. Front Immunol. 2024. PMID: 39372418 Free PMC article.

5

Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.

Xu CH, Wang W, Lin Y, Qian LH, Zhang XW, Wang QB, Yu LK. Xu CH, et al. Oncotarget. 2017 Mar 21;8(12):18746-18753. doi: 10.18632/oncotarget.13004. Oncotarget. 2017. PMID: 27816968 Free PMC article.

6

Akt/mTOR and AMPK signaling pathways are responsible for liver X receptor agonist GW3965-enhanced gefitinib sensitivity in non-small cell lung cancer cell lines.

Wang Q, Shen B, Qin X, Liu S, Feng J. Wang Q, et al. Transl Cancer Res. 2019 Feb;8(1):66-76. doi: 10.21037/tcr.2018.12.34. Transl Cancer Res. 2019. PMID: 35116735 Free PMC article.

7

Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor.

Lv YL, Yuan DM, Wang QB, Zhan P, Luo L, Lv TF, Liu HB, Li YF, Wen J, Song Y. Lv YL, et al. Med Oncol. 2012 Dec;29(4):2633-9. doi: 10.1007/s12032-012-0180-5. Epub 2012 Feb 22. Med Oncol. 2012. PMID: 22354764

8

Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.

Xu CH, Wang Y, Qian LH, Yu LK, Zhang XW, Wang QB. Xu CH, et al. Clin Respir J. 2017 Nov;11(6):765-771. doi: 10.1111/crj.12414. Epub 2016 Jan 25. Clin Respir J. 2017. PMID: 26605871

9

Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.

Xu CH, Sheng ZH, Hu HD, Hao KK, Wang QB, Yu LK. Xu CH, et al. Tumour Biol. 2014 Sep;35(9):8673-8. doi: 10.1007/s13277-014-2039-1. Epub 2014 May 29. Tumour Biol. 2014. PMID: 24870591

10

Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.

Xu C, Hao K, Hu H, Sheng Z, Yan J, Wang Q, Yu L. Xu C, et al. Among authors: wang q. Lung Cancer. 2014 Nov;86(2):268-73. doi: 10.1016/j.lungcan.2014.09.010. Epub 2014 Sep 22. Lung Cancer. 2014. PMID: 25262426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,705 results

Search Page

Filters